Human milk and colostrum samples were divided into an immunoglobulin and a nonimmunoglobulin fraction by immunosorbent chromatography. The ability of these fractions to inhibit bacterial cell adhesion and enterotoxin receptor binding of Vibrio cholerae and various Escherichia coli isolates was then tested by in vitro assays. The strongest effect was generally seen with the nonimmunoglobulin fractions, which were shown to significantly inhibit E. coli cell adhesion (hemagglutination) mediated by CFA/I, CFA/II, or K88 fimbriae (but not type 1 pili) and V. cholerae hemagglutination, as well as the binding of cholera toxin and E. coli heat-labile enterotoxin to GM1 ganglioside. Also, the immunoglobulin fractions had significant inhibitory activity in some of these systems. The results are interpreted to suggest that human milk and colostrum may contain secreted structure analogs of the cell receptors for some bacterial adhesins and enterotoxins; this might contribute to the protective effect of milk against enteric infections.
Diarrheal disease due to enteric infection is a major cause of death among children under 5 years of age. Infections are especially frequent at the time for weaning and in infants not receiving mother's milk (12) .
Enterotoxinogenic bacteria are responsible for a large proportion of these diseases. These bacteria have two main virulence properties. One is the ability to adhere to intestinal epithelium, which helps the bacteria to colonize and grow to large numbers in the small intestine. The other is the production of enterotoxin(s) stimulating intestinal electrolyte and water secretion (5, 17) . Both bacterial adhesion and enterotoxin action depend on the presence of specific intestinal receptors. Oligosaccharide structures on a lipid or protein backbone are likely receptors for enterotoxins as well as bacterial "adhesins." One receptor, that for cholera enterotoxin, has been well characterized and is known to be an acid glycolipid, the ganglioside GM1 (6) .
Numerous studies have indicated that breast milk protects against enteric infections (3, 4) .
Daily administration of human colostrum or milk to non-breast-fed, hospitalized infants has been reported to markedly reduce the frequency and severity of diarrheal disease among the infants (11, 22) .
The protective effect of colostrum and milk has been ascribed mainly to the high content of immunoglobulin, predominantly secretory immunoglobulin A (IgA), in these secretions. However, milk is also rich in glycolipids, other glycoproteins, and free oligosaccharides, including several blood group antigens (13 [8] ) replaced the saline.
Enterotoxins. Purified cholera toxin was prepared from V. cholerae 569B by affinity chromatography on a Spherosil-Gw2 ganglioside column as described (23) .
Crude E. coli heat-labile enterotoxin (LT) was prepared from fermentor-cultivated 286-C2 bacteria and consisted of concentrated culture filtrate (24) The column consisted of a top layer of 1.5 ml of Sepharose 4B (Pharmacia, Uppsala, Sweden) to which anti-human a-chain antibody (Dakopatts, Copenhagen, Denmark) had been covalently coupled and a bottom layer of 1.5 ml of Sepharose derivatized with anti-total gamma globulin including anti-light-chain antibody (Dakopatts). The coupling and chromatographic procedures were as earlier described (19) except that saline was used as the wash buffer. A 0.75-ml milk or colostrum sample was fractionated. After passage through the gel, the nonbound fraction was recirculated three times through the column to further deplete it from residual immunoglobulin and then washed out with saline. This resulted in a nonimmunoglobulin fraction, which was diluted 1:10 in relation to the applied milk or colostral sample. The specifically bound material in the column was eluted with 15 ml of acid buffer (1 M HAc, 0.5 M NaCl, 0.5 M glycine, pH 3.2), dialyzed against saline, and concentrated to a volume of 3 ml (immunoglobulin fraction).
This procedure gave nonimmunoglobulin fractions essentially quantitatively depleted of the different classes of immunoglobulins as determined by titration of a known antibody and for IgA also by a sensitive total IgA assay. The recovery of the various immunoglobulins in the immunoglobulin fractions was estimated to be 50 to 100% according to titration of a specific antibody and to be 15 to 29% according to the total IgA quantitation method (Table 1) .
Cell adhesion tests (hemagglutination). Celladhesive bacteria often agglutinate erythrocytes through multivalent attachment to cell surface structures identical or similar to the natural target cell b Titers of a specific antibody (anti-cholera toxin).
receptors (2, 8) . Hemagglutination is therefore a widely used test system of bacterial cell adhesion. We used hemagglutination of different species of erythrocytes to assay cell adhesion mediated by different bacterium-adhesive factors. The test systems used were agglutination of human group A erythrocytes by E. coli H10407 for CFA/I-mediated adhesion (2), of bovine erythrocytes by E. coli 411-5 and E1392-75 for CFA/II (1), of guinea pig erythrocytes by E. coli 853/ 67 for K88 (8) and by E. coli 286-C2 for type 1 pili (1), and of human group 0 erythrocytes for V. cholerae adhesion (8 (20) . We used a microtiter modification of the GMl-ELISA method (20) to measure receptor binding of these enterotoxins in saline supplemented with 0.5% bovine serum albumin (control) or serial fivefold dilutions of the test milk samples in the same buffer-protein solution. The toxin concentrations tested were 10 ng of cholera toxin and LT per ml, respectively. The inhibitory titer of the test samples was determined by interpolation of the dilution giving 50% reduction of toxin binding to Gm, (light absorbance at 405 nm after the ELISA detection steps). Samples were tested in duplicate.
Quantitation of immunoglobulins (ELISA). The predominating immunoglobulin in milk and colostrum is IgA (14) . Total IgA was determined with a sensitive immunobead-ELISA method in which Sepharose beads covalently derivatized with anti-IgA (BioRad, Richmond, Calif.) were incubated with the test samples, and the bound IgA was quantified by the aid of an anti-IgA-enzyme conjugate according to the ELISA principle (16) . The contents of IgA, IgM, and IgA in milk and colostrum fractions in relation to the original samples were also measured by titration of a specific antibody (anti-cholera toxin) known to be present in all samples. The ELISA method was used essentially as described earlier (7, 21) .
RESULTS
The milk and colostrum samples and their nonimmunoglobulin and immunoglobulin fractions were tested for their capacity to inhibit cell adhesion of various E. coli and V. cholerae strains by a hemagglutination system. This was done by comparing the number of bacteria needed for hemagglutination when the serially diluted bacteria were tested in buffer only with the number needed in the presence of a fixed concentration of the milk or colostrum samples and fractions. Since the variability of duplicate titrations was maximally twofold, a fourfold or greater increase in presence of test sample was considered to be significant. Figure 1 shows the results obtained with classical V. cholerae bacteria. When bacteria were titrated with the human target erythrocytes in buffer only, 2.5 x 106 bacteria gave 50% hemagglutination. Much higher bacterial numbers (18- trated in diluted milk or colostrum. The nonimmunoglobulin fractions of milk and colostrum (Swedish) had inhibitory activity similar to that of the whole unfractionated samples, whereas the immunoglobulin fractions gave little if any inhibition. This was in some contrast to the results obtained with milk sample II (Pakistani), in which case both the immunoglobulin and nonimmunoglobulin fractions gave significant inhibition (Fig. 1) .
Control studies showed that the inhibitions were not simple protein effects. In no instance did 5-mg/ml solutions of bovine serum albumin, ovalbumin, or ribonuclease, 10-mg/ml concentrations of casein or commercial human gamma globulin, or undiluted rabbit serum give any significant inhibition of V. cholerae hemagglutination. Conversely, as tested with serial dilutions of milk and a fixed number of bacteria, milk sample I could be diluted 200 to 600 times (three experiments) before it lost its ability to inhibit V. cholerae hemagglutination. The nonimmunoglobulin fraction had a similar inhibitory titer, whereas the immunoglobulin fraction lacked significant inhibitory activity (data not shown). (17) 10 (14) 7 The immunoglobulin fractions, on the other hand, had a much lower inhibitory effect. Also CFA/IH-and K88-mediated hemagglutination activities were significantly inhibited by milk or colostrum. Again, the predominating inhibitory activity resided in the nonimmunoglobulin fractions (Table 2) . Hemagglutination mediated by type 1 pili was not inhibited by any of the tested samples or fractions (Table 2) . Bovine serum albumin, ovalbumin, or ribonuclease (5 mg/ml) had no effect on hemagglutination in any system.
Enterotoxins. The milk and colostrum samples and fractions were also tested for their ability to inhibit binding of cholera and LT enterotoxins to GM1 ganglioside in an in vitro system. This was done by testing serial dilutions of the samples with a fixed toxin concentration and determining the dilution giving 50% inhibition of binding. All of the unfractionated samples had significant blocking titers, and the activity was present both in the immunoglobulin and nonimmunoglobulin fractions (Table 3 ). The blocking effect was generally similar for the two enterotoxins except for the colostral sample, which repeatedly inhibited LT binding to a greater extent than cholera toxin binding.
The specificity of blocking was controlled by experiments showing that specific rabbit antisera to cholera toxin or LT, tested in 1:1,000 dilutions, blocked binding of the respective toxin, as did 1 nmol of GM1 ganglioside per ml. In contrast, sera from preimmunization bleedings of rabbits, 10% (vol/vol) of fetal calf serum, or 50 mg of bovine serum albumin per ml had no blocking effect. Nonimmunoglobulin fraction 16 24 Immunoglobulin fraction 3 5.5 Milk II   Whole   29  33 Nonimmunoglobulin fraction 17 15 Immunoglobulin fraction 7 6 Colostrum Whole Human milk is known to contain several antimicrobial components in addition to immunoglobulin. These systems include chemotactic factors, lactoferrin, lysozyme, lactoperoxidase, interferon, and bifidus factor (14) . In the present study we did not characterize the chemical nature of the milk and colostral nonimmunoglobulin inhibitory substances, but it is unlikely that they are identical to any of the aforementioned factors since our test systems do not involve phagocytosis or bacterial multiplication. Probably the nonimmunoglobulin inhibitory components will instead prove to be structural analogs of the cell membrane receptors for the various bacterial adhesins and enterotoxins, respectively, acting through competitive inhibition. This means that they probably have sugar residues as the active moiety. In the case of the bacterial enterotoxins used in this study, it is known that these toxins bind to the specific carbohydrate sequence of GM1 ganglioside (6) . The cell receptors partaking in bacterial adhesion are likely to have a specific oligosaccharide recognition structure, too. This is suggested by the monosaccharide inhibition of adhesion in a few of the systems now tested (1, 8) as well as by the recent identification of a defined neutral glycolipid as the tentative adhesion receptor for E. coli in the urinary tract (10) .
The inhibitory activity observed in both the inmmunoglobulin and nonimmunoglobulin fractions of milk and colostrum may have a significant protective effect against diarrheal disease in infants. However, it should be emphasized that the present effects were demonstrated in in vitro test systems which may be too simple to fully reflect the in vivo situation in the gut. Hemagglutination by bacteria is probably mediated through binding to cell receptors which resemble but may not be identical to the natural target cell receptors. For instance, fucose has been shown to inhibit V. cholerae hemagglutination, although it does not prevent adhesion of cholera vibrios to intestinal cells (8) . In vivo intestinal absorption or degradation may also reduce the protective effect of the nonimmunoglobulin milk compounds. However, A.-B. Otnaess and A.-M. Svennerholm (unpublished data) have observed significant protective effect of a nonimmunoglobulin fraction of human milk against cholera toxin as well as E. coli LT challenge in the rabbit intestine.
